Is there Lyme borreliosis in French Guiana? Descriptive study among patients referred for a suspected Lyme borreliosis in an Amazonian hospital between 2010 and 2022

• Published in: Ticks and tick-borne diseases Vol. 15; no. 1; p. 102255
• Main Authors: Cartau, Tom, Eldin, Carole, Le Turnier, Paul, Eskenazi, Anaïs, Walter, Gaëlle, Coignard, Catherine, Schrooten, Ward, Caumes, Eric, Djossou, Félix, Epelboin, Loïc
• Format: Journal Article
• Language: English
• Published: Netherlands Elsevier GmbH 01.01.2024; Elsevier
• Subjects: Amazonia; Borrelia; Borrelia burgdorferi; Borreliosis; French Guiana; French Guiana - epidemiology; Functional somatic disorders; Humans; Life Sciences; Lyme disease; Lyme Disease - diagnosis; Lyme Disease - epidemiology; Retrospective Studies; South America; French Guiana; South America; Lyme disease; Borreliosis; Amazonia; Functional somatic disorders; French Guiana
• ISSN: 1877-959X; 1877-9603
• DOI: 10.1016/j.ttbdis.2023.102255

Lyme borreliosis (LB) existence in South America is debated, especially in the Amazon region. The infection with Lyme borreliae has never been reported in French Guiana where Borrelia burgdorferi sensu lato is not found in ticks. We describe the final diagnosis and presumed place of acquisition in patients consulting for suspicion of LB. We retrospectively collected data from all consecutive patients consulting for a suspicion of LB between 2010 and 2021 at Cayenne Hospital, French Guiana. Patients were classified by an adjudication committee as confirmed LB if they met the criteria of the French consensus, as possible LB if they had compatible symptoms and a good outcome after appropriate treatment, or excluded when a differential diagnosis was found. The place of acquisition was discussed in case of possible or confirmed case. Twenty-six patients were included. Rheumatologic symptoms were the most reported (88 %) followed by neurological symptoms (61 %). Twenty-four (92 %) of these patients were born out of French Guiana. Diagnosis of LB was considered as confirmed in 2 patients (8 %), for whom the place of acquisition was likely mainland France, and as possible in 3 patients (11 %) with early localized LB presumably acquired in French Guiana. Functional somatic disorders were diagnosed in 13 (50 %) patients whereas 9 (35 %) were found with another disease. This study did not confirm the acquisition of LB in French Guiana. However, three possible autochthonous cases encourage clinicians working in the Amazon area to stay aware of LB.